Remove 2027 Remove Immunization Remove Packaging
article thumbnail

Subcutaneous Biologics Market Analysis: Current Trends and Future Outlook

Roots Analysis

Moreover, protein-based drugs are also well tolerated inside the body, thereby reducing the chances of causing any immune response in the body. Currently, antibodies segment is likely to occupy the largest share in the overall market.

article thumbnail

Moving towards oral delivery of biologics

European Pharmaceutical Review

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. the enteric coating and the capsule dissolve.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Contamination Trends & Proposed Solutions

ISPE

The cases covered the same types of contaminants and impurities noted in Table 1: microbial contaminants, process-related im-purities, metal contaminants, packaging-related contaminants, drug cross-contamination, and an “unknown” category encompassing other contaminants associated with the manufacturing process, including those from cell culturing.

article thumbnail

How Will the Prescription Drug Provisions in the Inflation Reduction Act Affect Medicare Beneficiaries?

BuzzRx

This law includes a broad package of provisions concerning healthcare, taxes, and climate change. In 2018-2019, 25 states did not cover all the vaccines recommended by the Advisory Committee on Immunization Practices (ACIP). The Inflation Reduction Act of 2022 was signed into law by President Joe Biden on August 16, 2022.